Byrne S, Ortiz L, Mali P, Aach J, Church G. Multi-kilobase homozygous targeted gene replacement in human induced pluripotent stem cells. Nucleic Acids Res. 2015;43:e21 pubmed publisher

Modic M, Grosch M, Rot G, Schirge S, Lepko T, Yamazaki T, et al. Cross-Regulation between TDP-43 and Paraspeckles Promotes Pluripotency-Differentiation Transition. Mol Cell. 2019;74:951-965.e13 pubmed publisher

Ruiz Gutierrez M, Bölükbaşı Ö, Alexe G, Kotini A, Ballotti K, Joyce C, et al. Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells. JCI Insight. 2019;5: pubmed publisher

Trautsch I, Heta E, Soong P, Levent E, Nikolaev V, Bogeski I, et al. Optogenetic Monitoring of the Glutathione Redox State in Engineered Human Myocardium. Front Physiol. 2019;10:272 pubmed publisher

Umrath F, Steinle H, Weber M, Wendel H, Reinert S, Alexander D, et al. Generation of iPSCs from Jaw Periosteal Cells Using Self-Replicating RNA. Int J Mol Sci. 2019;20: pubmed publisher

Hirose T, Cabrera Socorro A, Chitayat D, Lemonnier T, Feraud O, Cifuentes Diaz C, et al. ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration. J Clin Invest. 2019;129:2145-2162 pubmed publisher

Ebrahimi A, Sevinç K, Gürhan Sevinç G, Cribbs A, Philpott M, Uyulur F, et al. Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming. Nat Chem Biol. 2019;15:519-528 pubmed publisher

Olova N, Simpson D, Marioni R, Chandra T. Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity. Aging Cell. 2019;18:e12877 pubmed publisher

Hayashi R, Ishikawa Y, Katayama T, Quantock A, Nishida K. CD200 facilitates the isolation of corneal epithelial cells derived from human pluripotent stem cells. Sci Rep. 2018;8:16550 pubmed publisher

Kutsche L, Gysi D, Fallmann J, Lenk K, Petri R, Swiersy A, et al. Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis. Cell Syst. 2018;7:438-452.e8 pubmed publisher

Shafa M, Yang F, Fellner T, Rao M, Baghbaderani B. Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers. Front Med (Lausanne). 2018;5:69 pubmed publisher

Parmar V, Parmar T, Arai E, Perusek L, Maeda A. A2E-associated cell death and inflammation in retinal pigmented epithelial cells from human induced pluripotent stem cells. Stem Cell Res. 2018;27:95-104 pubmed publisher

Kong T, Park J, Jang J, Kim C, Bae S, Choi Y, et al. Immunomodulatory effect of CD200-positive human placenta-derived stem cells in the early phase of stroke. Exp Mol Med. 2018;50:e425 pubmed publisher

Nie Y, Zheng Y, Ogawa M, Miyagi E, Taniguchi H. Human liver organoids generated with single donor-derived multiple cells rescue mice from acute liver failure. Stem Cell Res Ther. 2018;9:5 pubmed publisher

Verma N, Pan H, Dore L, Shukla A, Li Q, Pelham Webb B, et al. TET proteins safeguard bivalent promoters from de novo methylation in human embryonic stem cells. Nat Genet. 2018;50:83-95 pubmed publisher

Shukla V, Rao M, ZHANG H, Beers J, Wangsa D, Wangsa D, et al. ASXL3 Is a Novel Pluripotency Factor in Human Respiratory Epithelial Cells and a Potential Therapeutic Target in Small Cell Lung Cancer. Cancer Res. 2017;77:6267-6281 pubmed publisher

Roberts B, Haupt A, Tucker A, Grancharova T, Arakaki J, Fuqua M, et al. Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization. Mol Biol Cell. 2017;28:2854-2874 pubmed publisher

Makaryan V, Kelley M, Fletcher B, Bolyard A, Aprikyan A, Dale D. Elastase inhibitors as potential therapies for ELANE-associated neutropenia. J Leukoc Biol. 2017;102:1143-1151 pubmed publisher

Hirosawa M, Fujita Y, Parr C, Hayashi K, Kashida S, Hotta A, et al. Cell-type-specific genome editing with a microRNA-responsive CRISPR-Cas9 switch. Nucleic Acids Res. 2017;45:e118 pubmed publisher

Pashos E, Park Y, Wang X, Raghavan A, Yang W, Abbey D, et al. Large, Diverse Population Cohorts of hiPSCs and Derived Hepatocyte-like Cells Reveal Functional Genetic Variation at Blood Lipid-Associated Loci. Cell Stem Cell. 2017;20:558-570.e10 pubmed publisher

Panopoulos A, Smith E, ARIAS A, Shepard P, Hishida Y, Modesto V, et al. Aberrant DNA Methylation in Human iPSCs Associates with MYC-Binding Motifs in a Clone-Specific Manner Independent of Genetics. Cell Stem Cell. 2017;20:505-517.e6 pubmed publisher

Kotini A, Chang C, Chow A, Yuan H, Ho T, Wang T, et al. Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia. Cell Stem Cell. 2017;20:315-328.e7 pubmed publisher

Sweeney C, Zou J, Choi U, Merling R, Liu A, Bodansky A, et al. Targeted Repair of CYBB in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction. Mol Ther. 2017;25:321-330 pubmed publisher

Wang X, Lo C, Chen L, Ngan E, Xu A, Poon R. CDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotency. Cell Death Differ. 2017;24:38-48 pubmed publisher

Yamakawa T, Sato Y, Matsumura Y, Kobayashi Y, Kawamura Y, Goshima N, et al. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency. Stem Cells. 2016;34:2661-2669 pubmed publisher

Menendez J, Corominas Faja B, Cuyàs E, García M, Fernández Arroyo S, Fernández A, et al. Oncometabolic Nuclear Reprogramming of Cancer Stemness. Stem Cell Reports. 2016;6:273-83 pubmed publisher

Luo Y, Zhu D. Combinatorial control of transgene expression by hypoxia-responsive promoter and microrna regulation for neural stem cell-based cancer therapy. Biomed Res Int. 2014;2014:751397 pubmed publisher

Fatima A, Kaifeng S, Dittmann S, Xu G, Gupta M, Linke M, et al. The disease-specific phenotype in cardiomyocytes derived from induced pluripotent stem cells of two long QT syndrome type 3 patients. PLoS ONE. 2013;8:e83005 pubmed publisher

Xiong Z, LaDana C, Wu D, Cao K. An inhibitory role of progerin in the gene induction network of adipocyte differentiation from iPS cells. Aging (Albany NY). 2013;5:288-303 pubmed